Free Trial

Short Interest in Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY) Drops By 66.7%

Aspen Pharmacare logo with Medical background

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was short interest totalling 100 shares, a decline of 66.7% from the September 15th total of 300 shares. Based on an average daily volume of 300 shares, the short-interest ratio is currently 0.3 days.

Aspen Pharmacare Trading Down 1.2 %

APNHY traded down $0.13 during trading on Thursday, hitting $10.93. 161 shares of the stock traded hands, compared to its average volume of 542. Aspen Pharmacare has a twelve month low of $8.45 and a twelve month high of $13.69. The company has a quick ratio of 1.07, a current ratio of 1.81 and a debt-to-equity ratio of 0.30. The business has a 50 day moving average price of $11.89 and a 200 day moving average price of $12.14.

Aspen Pharmacare Cuts Dividend

The company also recently disclosed a dividend, which was paid on Tuesday, October 8th. Shareholders of record on Friday, September 20th were given a dividend of $0.1202 per share. The ex-dividend date of this dividend was Friday, September 20th.

Aspen Pharmacare Company Profile

(Get Free Report)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

Featured Stories

→ 625,000% Gain (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in Aspen Pharmacare right now?

Before you consider Aspen Pharmacare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.

While Aspen Pharmacare currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Tesla Stock Rockets 15% Post-Earnings

Tesla Stock Rockets 15% Post-Earnings

Will Tesla's rally continue, or is this the time to lock in gains? See how Thomas Hughes suggests playing the market in this exciting post-earnings period.

Related Videos

Tesla Stock: Profits vs. Price—Is It Time to Sell?
Top Stocks to Buy, Sell, and Hold Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines